| NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
| NCT00855101 | Healthy Volunteers | Drug: voriconazole | Pfizer | Phase 1 | 2009-04-01 | 2010-06-11 |
| NCT00300677 | Infections, Fungal | Drug: voriconazole | Pfizer|McLean Hospital. Belmont, MA. | Phase 4 | 2007-03-01 | 2009-10-05 |
| NCT01030653 | Healthy | Drug: Voriconazole low dose|Drug: Voriconazole high dose | Manjunath Prakash Pai|TKL Research, Inc.|Pfizer|University of Michigan | Phase 4 | 2009-11-01 | 2016-12-16 |
| NCT01151085 | Systemic Mycosis | Drug: Voriconazole | Pfizer | | 2006-04-01 | 2013-05-14 |
| NCT02100761 | Invasive Pulmonary Aspergillosis | Drug: Voriconazole | dingshifang|Shandong Provincial Hospital|Qianfoshan Hospital|Shandong thorax hospital|Jinan Military General Hospital|Jinan Central Hospital|Qilu Hospital | | 2014-06-01 | 2014-03-31 |
| NCT01101386 | Fungal Infection | Drug: Voriconazole | University of Colorado, Denver | Phase 4 | 2010-05-01 | 2014-05-20 |
| NCT01887457 | Immunocompromised Patient|Aspergillosis|Fusarium | Drug: VFEND | Brynn Chappell|The Christie NHS Foundation Trust | Phase 2 | 2014-09-01 | 2015-10-06 |
| NCT01660334 | Scedosporium Infection | Drug: Voriconazole | Pfizer | | 2006-07-01 | 2013-10-30 |
| NCT01185405 | Invasive Fungal Infection | Other: Use of different strategy for voriconazole dosage adjustment | Asan Medical Center | | 2010-08-01 | 2013-09-29 |
| NCT02110316 | Voriconazole|Bioavailability|Critically Ill | Other: Dosage form of voriconazole | University Medical Center Groningen | Phase 4 | 2015-06-01 | 2016-09-01 |
| NCT00893555 | Invasive Fungal Infection|Hematological Malignancy | Drug: voriconazole|Drug: voriconazole (dosing according to the SPC) | Jan-Willem C Alffenaar|University Medical Center Nijmegen|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|VU University Medical Center|Leiden University Medical Center|UMC Utrecht|Erasmus Medical Center|St. Antonius Hospital|Meander Medical Center|Haga Hospital, Leyweg|Klinikum Oldenburg gGmbH|University Medical Center Groningen | Phase 3 | 2009-04-01 | 2017-01-11 |
| NCT00792246 | Graft Versus Host Disease|Stem Cell Transplantation | Drug: voriconazole|Drug: voriconazole | Phillip Brian Smith|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|Duke University | Phase 1 | 2008-12-01 | 2012-11-09 |
| NCT00556998 | Pharmacokinetics | Drug: Voriconazole | Pfizer | Phase 2 | 2008-06-01 | 2016-03-31 |
| NCT01188759 | Aspergillosis|Invasive Pulmonary Aspergillosis|Neuroaspergillosis | Drug: Voriconazole|Drug: Anidulafungin|Drug: Voriconazole | Pfizer | Phase 3 | 2012-05-01 | 2012-05-10 |
| NCT01092832 | Candidiasis | Drug: voriconazole | Pfizer | Phase 3 | 2010-10-01 | 2016-05-17 |
| NCT01480219 | Non-Melanoma Skin Carcinoma | Drug: voriconazole (Vfend)|Other: no voriconazole (Vfend) | Pfizer|University of Southern California | | 2011-08-01 | 2013-02-04 |
| NCT01137292 | Invasive Fungal Infections | Drug: voriconazole (VFEND庐) | Pfizer | | 2007-04-01 | 2011-08-31 |
| NCT02396225 | Invasive Aspergillosis | Drug: Voriconazole | University of Aarhus|Aarhus University Hospital | | 2015-03-01 | 2016-12-22 |
| NCT02904434 | Infection | Other: Grapefruit Juice | Children's Hospital of Philadelphia | Phase 1 | 2016-09-01 | 2016-09-13 |
| NCT00531479 | Aspergillosis | Drug: voriconazole|Drug: anidulafungin|Drug: voriconazole | Pfizer | Phase 3 | 2008-07-01 | 2012-04-03 |
| NCT01976078 | Pharmacokinetics|Voriconazole | Drug: Midazolam/Ranitidine/Esomeprazole | Children's Hospital Los Angeles|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Phase 1 | 2012-09-01 | 2016-08-24 |
| NCT02283905 | Blastomycosis | Drug: amphotericin-B|Drug: voriconazole | University of Manitoba|Pfizer | Phase 4 | 2015-06-01 | 2016-08-31 |
